Register a trial

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT05173844




Registration number
NCT05173844
Ethics application status
Date submitted
13/12/2021
Date registered
30/12/2021

Titles & IDs
Public title
Digital Sleep Therapy for Older Adults With Cognitive Impairment
Scientific title
E-buddy Supported Digital Sleep Therapy for Older Adults With Cognitive Impairment
Secondary ID [1] 0 0
X21-0434
Universal Trial Number (UTN)
Trial acronym
ExCEED
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Insomnia Type; Sleep Disorder 0 0
Cognitive Impairment 0 0
Condition category
Condition code
Neurological 0 0 0 0
Other neurological disorders
Mental Health 0 0 0 0
Other mental health disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Other interventions - SleepFix mobile application

Experimental: Treatment - Participants will be instructed to use SleepFix mobile application for 3 weeks with an optional 3 weeks of additional therapy. Participants will complete daily sleep diary entries (which take less than 1 min) which are used to calculate the sleep window titration. SleepFix incorporates sleep restriction and stimulus control which have been shown to be the most powerful components of cognitive-behavioural therapy for insomnia - CBTi. It has been shown to produce rapid, clinically-meaningful insomnia symptom reduction in a shorter period of time compared with both face-to-face and digital CBTi. SleepFix does not require the user to complete modules and multiple components such as other digital CBTi programs (e.g. Sleepio). Further, it is personalised to the individual's current sleep patterns and requires minimal engagement compared to full CBTi.

No intervention: Control - Participants randomised to the control group will gain access to the first Sleep Health Education module immediately following completion of baseline questionnaires. There are 3 modules provided bi-weekly and the information in these modules is presented as a subdomain through the study website. The participant will receive a link to this information as each module is made available. Control participants will have full access to these modules for the duration of the study.


Other interventions: SleepFix mobile application
Digital behavioural therapy (dBTi) mobile application SleepFix® is specifically designed to treat insomnia and has been shown to be engaging and clinically efficacious.
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Change in Insomnia Severity Index
Timepoint [1] 0 0
Change score from baseline at 8 weeks
Secondary outcome [1] 0 0
Change in self-reported cognitive impairment
Timepoint [1] 0 0
Change score from baseline at 8 weeks
Secondary outcome [2] 0 0
Change in sleep metrics and quality
Timepoint [2] 0 0
Change score from baseline at 8 weeks
Secondary outcome [3] 0 0
Change in depressive symptoms
Timepoint [3] 0 0
Change score from baseline at 8 weeks
Secondary outcome [4] 0 0
Change in anxiety symptoms
Timepoint [4] 0 0
Change score from baseline at 8 weeks
Secondary outcome [5] 0 0
Change in fatigue
Timepoint [5] 0 0
Change score from baseline at 8 weeks
Secondary outcome [6] 0 0
Change in daytime sleepiness
Timepoint [6] 0 0
Change score from baseline at 8 weeks
Secondary outcome [7] 0 0
Change in quality of Life
Timepoint [7] 0 0
Change score from baseline at 8 weeks
Secondary outcome [8] 0 0
Digital literacy
Timepoint [8] 0 0
The questionnaire will only be collected at baseline

Eligibility
Key inclusion criteria
* Aged 50 years and older
* Insomnia Severity Index score =10
* Self-reported subjective cognitive impairment as defined as moderate subjective cognitive complaints (i.e. answers YES to have cognitive concerns OR thinking and memory skills are worse than same-age peers on the online screening)
* English speaking
* Access to a smartphone and willingness/proficiency to use a mobile app for healthcare
* Able to give informed online consent
Minimum age
50 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Neurological (e.g. Parkinson's, epilepsy) and major psychiatric disease (e.g. current major depression), dementia, history of cerebrovascular events (stroke, TIA); history of head injury with loss of consciousness > 30mins;
* Self-reported jetlag symptoms due to travel in the last 7 days;
* Current illicit substance use or alcohol intake suggestive of a hazardous or harmful pattern;
* Shift-work;
* Medical conditions with known effects on cognition and sleep (e.g. cancer with chemotherapy);
* Diagnosed obstructive sleep apnoea, or other sleep disorder including REM Sleep Behaviour Disorder, Restless Legs Syndrome or Narcolepsy.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
10/11/2022
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
31/12/2024
Actual
Sample size
Target
128
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
Woolcock Institute of Medical Research - Sydney
Recruitment postcode(s) [1] 0 0
2109 - Sydney

Funding & Sponsors
Primary sponsor type
Other
Name
Woolcock Institute of Medical Research
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Christopher Gordon, PhD
Address 0 0
Macquarie University
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Christopher Gordon
Address 0 0
Country 0 0
Phone 0 0
+61 2 9351 0586
Fax 0 0
Email 0 0
C.Gordon@mq.edu.au
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
What data in particular will be shared?
All de-identified data may be made available upon the Principal investigator's agreement with an amendment required to the approving ethics board.

Supporting document/s available: Study protocol, Informed consent form (ICF)
When will data be available (start and end dates)?
The study data will be available following all analyses.
Available to whom?
Contact the Coordinating Principal Investigator for access to data.
Available for what types of analyses?
How or where can data be obtained?


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT05173844